Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 06, 2026
Shopify (SHOP) Delivers Strong Q2 2026 Results, Shares Surge +20%

Shopify (SHOP) Delivers Strong Q2 2026 Results, Shares Surge +20%

Key Takeaways

  • Revenue surged 34% year-over-year to $3.58 billion, comfortably beating the consensus estimate of $3.45 billion.
  • Adjusted earnings per share (EPS) reached $0.42, surpassing analyst expectations of $0.40 and marking a 20% increase from $0.35 a year ago.
  • Gross Merchandise Volume (GMV) climbed 32% to $115.6 billion, representing the fifth consecutive quarter of GMV growth above 30%.
  • Free cash flow jumped to $654 million, producing an 18% free cash flow margin, up from $422 million in the prior-year period.
  • Q3 revenue guidance exceeded projections, with management forecasting low-thirties percentage growth versus analyst estimates of roughly 26%.
  • Shares soared approximately 20% in response to the report, partially reversing a year-to-date decline of about 23%.

Earnings Context and Why It Matters

Shopify's Q2 2026 report arrived at a pivotal moment. Heading into the release, the stock had fallen roughly 23% year-to-date amid mounting concerns that emerging artificial intelligence (AI) tools from competitors such as Meta Platforms could erode demand for Shopify's e-commerce platform. The company had also disappointed investors with an EPS miss in Q1 2026, intensifying scrutiny around profitability and cost discipline. Against this backdrop, the Q2 results served as a critical test of Shopify's ability to sustain high growth while defending its competitive moat. The decisive beat across revenue, earnings, GMV, and free cash flow provided a powerful rebuttal to bearish narratives and reframed the conversation around AI from a threat to a growth driver. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

Shopify reported Q2 2026 revenue of $3.58 billion, up 34% from $2.68 billion in the same quarter last year and ahead of the $3.45 billion consensus. Adjusted EPS came in at $0.42, beating the $0.40 estimate. On a GAAP (Generally Accepted Accounting Principles) basis, net income reached $1.5 billion, or $1.16 per share, compared to $906 million a year earlier.

Revenue growth was broad-based. Merchant Solutions revenue — which includes payment processing, shipping, and other transaction-based services — climbed 37% to $2.78 billion. Subscription Solutions revenue grew 22% to $802 million, driven by steady adoption of Standard plans and enterprise-tier Shopify Plus offerings.

GMV hit $115.6 billion, up 32% year-over-year and above the $111.4 billion consensus. Payments penetration reached 68% of global GMV, up three percentage points from the prior year. International GMV grew 37%, B2B (business-to-business) GMV surged 76%, and offline GMV rose 32%. Operating income jumped 68% to $488 million, while operating expenses came in at 34% of revenue — a nearly two-point improvement from Q2 2025. I ran a quick check on the sector trends with Tickeron’s AI Pattern Search Engine to confirm the broad strength here.

Market Reaction and Investor Sentiment

The market responded emphatically to Shopify's results. Shares surged approximately 20% in trading on August 5, with pre-market gains reaching as high as 26%. The rally was fueled by the combination of a clean top-and-bottom-line beat, robust GMV acceleration, and third-quarter guidance that came in well above Wall Street's expectations. Investors who had braced for AI-driven margin compression were instead presented with expanding free cash flow margins and improving operating leverage. The quarter also offered compelling evidence that Shopify's own AI investments — including automated storefront tools and AI-powered product catalog features — are translating into tangible merchant adoption and higher order volumes. AI-driven traffic and orders to Shopify stores reportedly tripled year-over-year, strengthening the bull case.

Forward Outlook and Key Factors to Monitor

Looking ahead, Shopify's Q3 guidance sets a confident tone. Management expects revenue growth in the low-thirties percentage range year-over-year, significantly above the roughly 26% that analysts had projected. Gross profit dollar growth is forecast in the mid-to-high twenties percentage range, with the midpoint around 27.5% representing a modest deceleration from Q2's 31% pace — a normalization that management attributed partly to product mix shifts toward lower-margin merchant services.

Free cash flow margin is expected to remain strong, in the high-teens to low-twenties range, while operating expenses are projected at 33% to 34% of revenue. These metrics suggest Shopify is striking a deliberate balance between reinvesting for growth and delivering improving profitability.

Several factors warrant ongoing attention. First, the pace of enterprise merchant adoption remains a key vector. Shopify added notable brands — including Balmain, Guess, Avon, and e.l.f. Cosmetics — during the quarter, signaling momentum in the upper end of the market. Second, international expansion and B2B commerce represent significant untapped addressable markets. Third, the evolving competitive landscape, particularly around AI-native shopping tools from Meta and others, will continue to shape sentiment. Finally, investors will monitor whether Shopify can sustain its elevated GMV growth trajectory as macroeconomic conditions evolve and consumer spending patterns shift. From what I see, the AI angle on Shopify itself looks worth tracking closely with tools like Tickeron’s AI Trend Prediction Engine.

AI Tools for Post-Earnings Analysis

I often rely on Tickeron’s AI Screener after big earnings reports like this one. It lets me quickly filter stocks by fundamentals, technical patterns, and AI signals to spot similar opportunities or compare performance across the sector. The tool has been helpful for surfacing ideas without manual digging, especially when evaluating momentum following results like Shopify’s.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SHOP

SHOP in upward trend: price rose above 50-day moving average on July 24, 2026

SHOP moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend. In of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on SHOP as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SHOP just turned positive on August 05, 2026. Looking at past instances where SHOP's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for SHOP crossed bullishly above the 50-day moving average on July 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SHOP advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where SHOP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where SHOP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHOP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SHOP broke above its upper Bollinger Band on August 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHOP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.749) is normal, around the industry mean (27.954). P/E Ratio (97.459) is within average values for comparable stocks, (81.868). Projected Growth (PEG Ratio) (2.612) is also within normal values, averaging (1.680). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (14.144) is also within normal values, averaging (52.021).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHOP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Zoom Communications Inc (NASDAQ:ZM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.01B. The market cap for tickers in the group ranges from 291 to 222.3B. SAP holds the highest valuation in this group at 222.3B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 7%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 6%. YXT experienced the highest price growth at 686%, while YAAS experienced the biggest fall at -85%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 47% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
SHOP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of eCommerce website that allows customers to sell online by providing software to create an online store

Industry PackagedSoftware

Profile
Details
Industry
Information Technology Services
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.